Search Results for 'event survival'
event survival published presentations and documents on DocSlides.
Discrete-Time Survival Analysis
by cheryl-pisano
Presented by . Chien. -ti Lee. September 12, 2014...
Active learning based survival regression for censored data
by phoebe-click
Bhanukiran . Vinzamuri. (bhanukiranv@wayne.edu)....
Using Survival Analysis to analyze degree completion
by briana-ranney
Janice Love. University of California, Los Angele...
Survival Analysis for Randomized Clinical Trials
by celsa-spraggs
Ziad. . Taib. March . 3, 2014. I The log-rank te...
BMS 617 Lecture 9 : Survival Curves
by min-jolicoeur
Marshall University Genomics Core Facility. Survi...
Cox ProportionalHazards Regression for Survival Data Appendix to An R and SPLUS Companion to Applied Regression JohnFox Februrary Introduction Survival analysis examines and models the time it takes
by cheryl-pisano
The prototypical such event is death from which t...
Supplemental Digital Content Figure 1A
by stefany-barnette
A. Academic/Research Program. Extent of Lung Rese...
Survival Analysis and the ACT study
by stefany-barnette
Laura Gibbons, . PhD. Thanks to . An Introduction...
Blinded Sample Size Re-estimation in a Phase III Study Investigating Progression Free Survival
by naomi
David Morgan (King’s College, London / Consultan...
Nonparametric Methods for Comparing Survival Distributions
by ella
Comparison of Two Survival Distribution. n. 1. =Pa...
Survival Curves What do they tell? 1 2 3 4
by ellena-manuel
Survival Curves What do they tell? 1 2 3 4 5 6 7 8...
Identification of Prognostic Factors Related to Survival Ti
by myesha-ticknor
Non-Proportional Hazards Models . Danny . Tshitum...
Lecture 20: Study Design and Sample Size Estimation in TTE
by sherrill-nordquist
Study Design and Sample Size. Ideally we are invo...
Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t
by sherrill-nordquist
Yes . Deborah . Schrag. , MD, MPH. No. John L. Ma...
Randomized Comparison of Ibrutinib Versus Ofatumumab in Rel
by jane-oiler
Presented By John Byrd at 2014 ASCO Annual Meetin...
Ibrutinib: Analysis of Pivotal Data
by alida-meadow
Richard R. Furman, MD. CLL Research Center. BCR-a...
More and earlier cardiovascular events (CVE) and shorter overall survival (OS) in HIV-positive pati
by trish-goza
sex. Stefan . Esser1, Marina Arendt2. , Robert Ja...
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
by bikersjoker
patients with . advanced breast . cancer and a ger...
First Response to Cardiac Arrest
by SmoochieBoochie
Blake Wachter, MD, PhD. April 2, 2016. The Victim ...
For the trainer: Please note this slide deck is not a train the trainer presentation with fully dev
by lauren
If slides are used, please use the citation below ...
Active Shooter: Safety Training & preparedness
by badra
Tommy Blankenship. Senior safety specialist. Depar...
Case presentation 9 year old boy child with acute abdominal pain
by bery
PMH:negative. Primary physical exam….. CBC perfe...
Table 1. Patients and tumor samples characteristics according to treatment program
by ruby
Therapeutic. p. rogram . . Total. (%). Neuro - ...